SNTA1 gene rescues ion channel function and is antiarrhythmic in cardiomyocytes derived from induced pluripotent stem cells from muscular dystrophy patients

  1. Eric N Jimenez-Vazquez
  2. Michael Arad
  3. Álvaro Macías
  4. Maria L Vera-Pedrosa
  5. Francisco Miguel Cruz
  6. Lilian K Gutierrez
  7. Ashley J Cuttita
  8. André Monteiro da Rocha
  9. Todd J Herron
  10. Daniela Ponce-Balbuena
  11. Guadalupe Guerrero-Serna
  12. Ofer Binah
  13. Daniel E Michele
  14. José Jalife  Is a corresponding author
  1. Department of Internal Medicine and Molecular and Integrative Physiology, Center for Arrhythmia Research, University of Michigan, United States
  2. Leviev Heart Center, Sheba Medical Center, Tel Hashomer, and Tel Aviv University, Israel
  3. Centro Nacional de Investigaciones Cardiovasculares (CNIC) Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
  4. Department of Molecular and Integrative Physiology, University of Michigan Medical School, United States
  5. Department of Physiology, Biophysics and Systems Biology, Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Israel
8 figures, 1 video and 8 additional files

Figures

Altered ECG and arrhythmias in Duchenne Muscular Dystrophy (DMD) patients with cardiomyopathy.

(a) Abnormal ECG in a 34-year-old DMD male: PR interval, 116 ms; QRS, 120 ms; QT/QTc, 404/472 ms; and PRT axes, 18-16-90. (b) Holter recording from the same patient shows nonsustained monomorphic …

Duchenne Muscular Dystrophy (DMD) patient-specific iPSC-CMs do not express dystrophin.

(a) Top right, control and heterozygous female iPSC-CMs express dystrophin. iPSC-CMs from hemizygous dystrophic cell lines (Males 1 and 2) did not express the large dystrophin isoform. Top left, …

Figure 3 with 2 supplements
Action potential properties in control, Duchenne Muscular Dystrophy (DMD), and female iPSC-CMs.

(a) Representative action potentials of ventricular-like iPSC-cardiomyocytes from Control 1, heterozygous female, and DMD individuals. The respective dV/dt trace is shown below each action …

Figure 3—figure supplement 1
Electrophysiological analysis in Control 2 (human foreskin-derived BJ iPSC-CMs).

(a) Representative AP trace of ventricular-like control BJ iPSC-CMs obtained at 1 Hz of pacing. Inset. First derivative with respect to time (dV/dt). (b–f) Action potential properties. Recordings at …

Figure 3—figure supplement 2
Action potential properties of control, hemizygous, and heterozygous Duchenne Muscular Dystrophy (DMD) iPSC-CMs paced at 2 Hz.

(a) Maximal AP upstroke velocity was reduced in both hemizygous (****p < 0.0001), and the heterozygous female (***p = 0.0002) iPSC-CMs compared to control. (b–d) Overshoot values were similar among …

Figure 4 with 2 supplements
Conduction velocity (CV) is slower in iPSC-CM monolayers from Duchenne Muscular Dystrophy (DMD) hemizygous male and heterozygous female than control.

(a) Activation maps of action potential propagation at 1 Hz. Each color represents a different activation time with time zero appearing in green (¤ indicates the location of the stimuli for each …

Figure 4—figure supplement 1
Conduction velocity in control BJ iPSC-CM (Control 2) monolayer.

(a) Activation maps of action potential propagation at 1 Hz. Each color represents a different activation time with time zero appearing in green (¤ indicates the location of the stimuli for each …

Figure 4—figure supplement 2
Cx43 expression level in control, hemizygous, and heterozygous Duchenne Muscular Dystrophy (DMD) iPSC-CMs.

(a) Typical western blot for connexin43 expression. About 50 k cells were collected to quantify total dystrophin, connexin43, and actinin levels in iPSC-CMs. (b) Scatter plots of Cx43 detected in …

Figure 4—figure supplement 2—source data 1

Full unedited gel showing Dystrophin, Actinin and Cx43 expression levels by WB technique.

https://cdn.elifesciences.org/articles/76576/elife-76576-fig4-figsupp2-data1-v1.zip
Figure 5 with 4 supplements
Sodium (INa) and Inward rectifier potassium (IK1) channel properties in control, Duchenne Muscular Dystrophy (DMD), and female iPSC-cardiomyocytes.

(a) Superimposed INa current traces for Control 1, hemizygous, and heterozygous iPSC-CMs elicited by the pulse protocol shown by the inset. (b) Left, normalized current–voltage (I/V) relationships. I

Figure 5—figure supplement 1
Cell capacitance.

No statistically significant differences were observed among control (32 ± 2 pF), female (39 ± 3 pF; p = 0.0715), and Duchenne Muscular Dystrophy (DMD) iPSC-CMs (38 ± 3 pF, p = 0.3257 for Male 1; …

Figure 5—figure supplement 2
Calcium channel properties in control, Duchenne Muscular Dystrophy (DMD), and female iPSC-CMs.

(a) Original calcium current traces obtained from all iPSC-CMs elicited by depolarizing potential as shown in the inset. (b) Current–voltage relationships showing no significant differences among …

Figure 5—figure supplement 3
SCN5A, KCNJ2, and CACNA1C mRNA expression in control, Duchenne Muscular Dystrophy (DMD), and female iPSC-CMs.

(a) SCN5A mRNA expression was increased in iPSC-CMs from hemizygous and heterozygous DMD individuals (top), as well as in the human left ventricle heart tissue from a Becker MD individual compared …

Figure 5—figure supplement 4
NaV1.5 protein level is significantly reduced in patient-specific Duchenne Muscular Dystrophy (DMD) iPSC-CMs.

(a) Representative western blot for each antibody used. The bands within the blue rectangles at ~250 KDa and below 50 KDa correspond to NaV1.5 and Kir2.1, respectively. About 50 k cells were …

Transfection of SNTA1 rescues membrane levels of Kir2.1 and NaV1.5 proteins in iPSC-CMs from Male 1 patient.

(a) Cartoon illustrating nonviral piggy-bac vector encoding SNTA1 for transfection in Male 1 iPSC-CMs. SNTA1 coding region (CDS) is driven by the CAG promoter and followed by green fluorescence …

SNTA1 expression restores the electrophysiological deficiencies in Duchenne Muscular Dystrophy (DMD) iPSC-CMs.

(a, b) Normalized current–voltage (I/V) relationships for INa and IK1 in Male 1 before (black) and after (red) syntrophin expression at the specified voltages. Two-way analysis of variance (ANOVA) …

Figure 7—source data 1

SNTA1 IV IK1 and IV INA (Figure 7A and B); and, Action potential properties (Figure 7C).

https://cdn.elifesciences.org/articles/76576/elife-76576-fig7-data1-v1.zip
Figure 8 with 1 supplement
SNTA1 expression prevents reentrant arrhythmias in Duchenne Muscular Dystrophy (DMD) iPSC-CM monolayers.

(a) Optical maps of action potential propagation during pacing at 1 Hz. Each color represents a different activation time with time zero appearing in blue (star below each monolayer indicates the …

Figure 8—source data 1

Conduction Velocity and APD90 in the absence and in the presence of SNTA1 expression.

https://cdn.elifesciences.org/articles/76576/elife-76576-fig8-data1-v1.zip
Figure 8—figure supplement 1
SNTA1 expression rescues contractility in Duchenne Muscular Dystrophy (DMD) iPSC-CM monolayers.

Contractility measured by cell shortening in spontaneously beating iPSC-CM monolayers from DMD hemizygous Male 1 is reduced with respect to control and rescued fully by SNTA1 expression. (a) …

Videos

Video 1
Duchenne Muscular Dystrophy (DMD) male arrhythmia patterns.

Movie # i Control iPSC-CM monolayer showing slow and organized spontaneous activity. Movies # ii–v. DMD hemizygous Male 1 iPSC-CM monolayers are inducible of high-frequency reentry maintained by one …

Additional files

Supplementary file 1

Action potential parameters of iPSC-CMs paced at 1 and 2 Hz.

https://cdn.elifesciences.org/articles/76576/elife-76576-supp1-v1.docx
Supplementary file 2

Action potential parameters of iPSC-CMs paced at 1 and 2 Hz.

https://cdn.elifesciences.org/articles/76576/elife-76576-supp2-v1.docx
Supplementary file 3

Action potential parameters of iPSC-CMs at 1 and 2 Hz, Control 1 versus Control 2.

https://cdn.elifesciences.org/articles/76576/elife-76576-supp3-v1.docx
Supplementary file 4

Biophysical parameters of DMD, and female iPSC-CMs versus Control 1.

https://cdn.elifesciences.org/articles/76576/elife-76576-supp4-v1.docx
Supplementary file 5

Biophysical parameters of DMD, and female iPSC-CMs versus Control 2.

https://cdn.elifesciences.org/articles/76576/elife-76576-supp5-v1.docx
Supplementary file 6

Biophysical parameters of iPSC-CMs, Control 1 versus Control 2.

https://cdn.elifesciences.org/articles/76576/elife-76576-supp6-v1.docx
Supplementary file 7

Primers used in mRNA analysis.

https://cdn.elifesciences.org/articles/76576/elife-76576-supp7-v1.docx
Transparent reporting form
https://cdn.elifesciences.org/articles/76576/elife-76576-transrepform1-v1.pdf

Download links